Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthequity (HQY) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Healthequity (HQY) over the last 12 years, with Q4 2025 value amounting to $1.3 billion.

  • Healthequity's Total Liabilities fell 730.57% to $1.3 billion in Q4 2025 from the same period last year, while for Oct 2025 it was $1.3 billion, marking a year-over-year decrease of 730.57%. This contributed to the annual value of $1.3 billion for FY2025, which is 1814.99% up from last year.
  • As of Q4 2025, Healthequity's Total Liabilities stood at $1.3 billion, which was down 730.57% from $1.3 billion recorded in Q3 2025.
  • In the past 5 years, Healthequity's Total Liabilities registered a high of $1.4 billion during Q4 2024, and its lowest value of $1.1 billion during Q4 2023.
  • In the last 5 years, Healthequity's Total Liabilities had a median value of $1.2 billion in 2021 and averaged $1.2 billion.
  • Its Total Liabilities has fluctuated over the past 5 years, first tumbled by 1368.29% in 2021, then skyrocketed by 2334.85% in 2024.
  • Over the past 5 years, Healthequity's Total Liabilities (Quarter) stood at $1.2 billion in 2021, then fell by 3.76% to $1.2 billion in 2022, then dropped by 6.44% to $1.1 billion in 2023, then increased by 23.35% to $1.4 billion in 2024, then decreased by 7.31% to $1.3 billion in 2025.
  • Its Total Liabilities was $1.3 billion in Q4 2025, compared to $1.3 billion in Q3 2025 and $1.3 billion in Q2 2025.